Treatment
Treatment clinical trials
We’re tracking 8,593 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06365502Recruiting
Preventing future heart attacks with drug-coated balloon
This trial tests whether a balloon coated with medicine (drug-coated balloon) can prevent future heart attacks by treating high-risk plaques in arteries that are not the one that caused your current heart attack. You may qualify if you already had a stent placed and have another mildly blocked artery with certain vulnerable features.
Beijin, Beijing MunicipalityAges 18–80 - NCT06366360Recruiting
Virtual reality treatment for stroke-related neglect
This study tests whether virtual reality training can help people who, after a stroke, have trouble noticing things on one side of their body or space (called unilateral neglect). You would use a VR headset to practice tasks that may retrain your brain's attention.
Saint-MauriceAges 18 years+ - NCT06367088RecruitingPhase 2
Combination drug therapy for advanced triple-negative breast cancer
This trial tests a new drug (cadonilimab) plus chemotherapy for people with advanced triple-negative breast cancer that has come back or spread. It aims to see if the combination works better than standard treatment.
Wuhan, HubeiAges 18–70 - NCT06367465Recruiting
Hepatitis C treatment during pregnancy
This study tests whether treating hepatitis C during pregnancy is feasible and acceptable for pregnant women who have a history of drug use. If you qualify, you may receive treatment that could help protect your health and your baby's health.
St Louis, MissouriAges 18 years+ - NCT06367764Recruiting
PTSD treatment study for sexual and gender minorities
This study compares different treatments for PTSD specifically designed for people who are sexual or gender minorities. It aims to find which approach works best for this community, and you can join sessions in person or by video.
Palo Alto, CaliforniaAges 18 years+ - NCT06368414RecruitingPhase 2
Stopping TKI in CML after asciminib
This trial tests if people with chronic myeloid leukemia (CML) who have already tried to stop their TKI medication once and lost a deep remission, can safely stop their TKI again after taking a newer drug called asciminib. The goal is to stay in remission (no detectable leukemia) without needing daily medication.
Incheon, IncheonAges 19 years+ - NCT06369714Recruiting
Brain-training video game for ADHD in children
This trial tests a digital therapy that uses neurofeedback (brainwave training) to help children with ADHD improve focus and attention. It's designed for kids ages 6 to 11 who haven't had ADHD treatment in the last month.
Shanghai, Shanghai MunicipalityAges 6–12 - NCT06370988Recruiting
Theta-burst stimulation for bipolar depression
This study tests a type of brain stimulation (theta-burst TMS) to see if it helps improve depression in people with bipolar disorder. It might be a good option if you have tried medication but still feel depressed.
Toronto, OntarioAges 18–65 - NCT06371768Recruiting
Helping Young Cancer Survivors Manage Symptoms & Transition to Care
This study is designed to help adolescent and young adult cancer survivors manage symptoms and smoothly transition to post-treatment care. If you finished treatment for certain cancers within the past 1 to 5 years, you may be able to join.
Durham, North CarolinaAges 18–39 - NCT06373484Recruiting
Matching treatment for kids with disruptive behavior and their parents
This study aims to find the best treatment approach for children with disruptive behavior by matching them to either group or individual therapy. It could help if your child struggles with behavior like defiance or conduct issues, and you're willing to participate in treatment.
Toronto, OntarioAges 6–12 - NCT06374589Recruiting
Closing the loop on oxygen use during high flow therapy
This trial tests a system that automatically adjusts oxygen levels for patients receiving high flow oxygen therapy. The goal is to see if it can keep oxygen levels in a safe range better than usual care.
IstanbulAges 18 years+ - NCT06374745Recruiting
A surgery plan for chronic lymphedema after breast cancer
This trial looks at a combined approach to treat chronic lymphedema (long-term arm swelling) after breast cancer treatment. Doctors will use different surgical techniques, alone or together, to see which works best.
BaselAges Any age - NCT06375005RecruitingPhase 2
Telitacicept for early diffuse scleroderma
This trial tests a new drug called telitacicept for people with recently diagnosed, rapidly progressing systemic sclerosis (scleroderma). It aims to see if the drug can slow down skin thickening and other symptoms.
Yangzhou, JiangsuAges 18–70 - NCT06375473Recruiting
Study of irinotecan liposome for pancreatic cancer
This study looks at how well a specific type of chemotherapy called irinotecan hydrochloride liposome works in people with pancreatic cancer. Researchers want to understand its effects in real-world settings, which may help doctors choose the best treatment for patients.
Hefei, AnhuiAges 18–100 - NCT06375486RecruitingPhase 2
Ivonescimab and HAIC for Unresectable Liver Cancer
This trial tests a combination of a targeted immunotherapy drug (ivonescimab) and a liver-directed chemotherapy infusion (HAIC) for people with liver cancer that cannot be removed by surgery. It may be an option if you have not had prior systemic treatment for your liver cancer.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06376669RecruitingPhase 2
Proton beam radiation for kidney cancer
This trial tests a precise type of radiation called stereotactic body proton therapy for people with kidney cancer who cannot have surgery or other local treatments. It aims to see if this focused radiation can control the tumor with fewer side effects.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06377189Recruiting
Mental health support from a specialist in primary care
This study tests whether adding a psychiatric consultant to your primary care team can help people struggling with mental distress or complex medical issues. If you're already seeing a primary care doctor and need extra mental health support, this might be for you.
Neuchâtel, Canton of NeuchâtelAges 18 years+ - NCT06378138RecruitingPhase 2/Phase 3
Testing a new drug combo for untreated CLL or SLL
This trial tests two new oral medications (ICP-248 and Orelabrutinib) together as a first treatment for people with CLL or SLL. The goal is to see if this combination works better than current options and is safe for newly diagnosed patients.
Bengbu, AnhuiAges 18–80 - NCT06378190RecruitingPhase 1/Phase 2
New CAR-T cell therapy for relapsed B-cell lymphoma
This trial tests a new type of CAR-T cell therapy (a treatment that uses your own immune cells to fight cancer) for people with B-cell lymphomas that have come back or not responded to standard treatments. It aims to see if this new manufacturing method is safe and effective.
Barcelona, BarcelonaAges 18–80 - NCT06378099Recruiting
Standard treatment for minor ailments at pharmacies
This study tests whether using standard treatment guidelines helps pharmacists better manage common minor illnesses like colds, headaches, and menstrual cramps. If you have one of these symptoms and buy your own medicine at a pharmacy in Medellín, you might be a good fit.
Medellín, AntioquiaAges 18–65 - NCT06379243Recruiting
Predicting future spinal fractures after osteoporosis treatment
This study is testing a new way to predict if your spine might break again after you have treatment for a fracture caused by osteoporosis. If you have a recent spinal fracture from weak bones and are getting a cement injection (PVP or PKP), researchers want to check your information to see how well their risk model works for people like you.
Guangzhou, GuangdongAges 50–90 - NCT06380387Recruiting
Metabolism in children before and after brain tumor treatment
This study looks at how the body's energy use (metabolism) changes in children with a brain tumor before and after treatment. The goal is to understand how the tumor and its treatment affect the body, which may help improve care in the future.
Copenhagen, Copenhagen ØAges 6–18 - NCT06380517RecruitingPhase 3
Headset therapy vs patching for lazy eye in children
This study tests a new way to treat lazy eye (amblyopia) in 4 to 7 year olds using special shows watched through a headset (dichoptic therapy). It compares this to the standard treatment of wearing a patch over the stronger eye. The goal is to see if the headset therapy works as well or better than patching.
Birmingham, AlabamaAges 4–7 - NCT06380504Recruiting
Increasing severe malnutrition treatment in Ethiopia
This trial tests ways to help more children with severe acute malnutrition (SAM) get treatment in Ethiopia. If your child has SAM or is already in a SAM treatment program, they may be eligible.
JimmaAges 6 months–5 years
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,593 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.